GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cerner Corp (NAS:CERN) » Definitions » EBIT

Cerner (Cerner) EBIT : $777 Mil (TTM As of Mar. 2022)


View and export this data going back to 1986. Start your Free Trial

What is Cerner EBIT?

Cerner's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2022 was $252 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2022 was $777 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cerner's annualized ROC % for the quarter that ended in Mar. 2022 was 13.96%. Cerner's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was 52.50%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cerner's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was 2.71%.


Cerner EBIT Historical Data

The historical data trend for Cerner's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cerner EBIT Chart

Cerner Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 975.14 808.84 668.98 1,020.55 742.93

Cerner Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 218.06 49.56 224.92 250.39 251.98

Competitive Comparison of Cerner's EBIT

For the Health Information Services subindustry, Cerner's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cerner's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cerner's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cerner's EV-to-EBIT falls into.



Cerner EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $777 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cerner  (NAS:CERN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cerner's annualized ROC % for the quarter that ended in Mar. 2022 is calculated as:

ROC % (Q: Mar. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2021 ) + Invested Capital (Q: Mar. 2022 ))/ count )
=1007.936 * ( 1 - 18.21% )/( (5964.288 + 5849.812)/ 2 )
=824.3908544/5907.05
=13.96 %

where

Invested Capital(Q: Dec. 2021 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7434.158 - 646.674 - ( 842.469 - max(0, 1626.258 - 2449.454+842.469))
=5964.288

Invested Capital(Q: Mar. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7374.231 - 643.707 - ( 880.712 - max(0, 1378.872 - 2467.857+880.712))
=5849.812

Note: The Operating Income data used here is four times the quarterly (Mar. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Cerner's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2021  Q: Mar. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1007.936/( ( (1739.111 + max(205.727, 0)) + (1686.97 + max(208.273, 0)) )/ 2 )
=1007.936/( ( 1944.838 + 1895.243 )/ 2 )
=1007.936/1920.0405
=52.50 %

where Working Capital is:

Working Capital(Q: Dec. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1161.361 + 28.159 + 417.465) - (646.674 + 531.234 + 223.35)
=205.727

Working Capital(Q: Mar. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1178.037 + 27.704 + 381.404) - (643.707 + 456.929 + 278.236)
=208.273

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cerner's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2022 )
=776.86/28646.382
=2.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cerner EBIT Related Terms

Thank you for viewing the detailed overview of Cerner's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cerner (Cerner) Business Description

Traded in Other Exchanges
N/A
Address
2800 Rock creek Parkway, North Kansas City, MO, USA, 64117
Cerner is a leading supplier of healthcare information technology solutions and tech-enabled services. The company is a long-standing market leader in the electronic health record industry, and along with rival Epic Systems corners a majority of the market for acute care EHR within health systems. The company is guided by the mission of the founding partners to provide seamless medical records across all healthcare providers to improve outcomes. Beyond medical records, the company offers a wide range of technology that supports the clinical, financial, and operational needs of healthcare facilities.
Executives
Michael R. Battaglioli officer: VP & Chief Accounting Officer 2800 ROCKCREEK PARKWAY NORTH KANSAS CITY MO 64117
Tracy L Platt officer: Chief Human Resources Officer 2800 ROCKCREEK PARKWAY NORTH KANSAS CITY MO 64117
Nasim Afsarmanesh officer: EVP & Chief Health Officer 2800 ROCK CREEK PARKWAY NORTH KANSAS CITY MO 64117
David T Feinberg director, officer: President and CEO 1299 OCEAN AVENUE, SUITE 1000, SANTA MONICA CA 90401
Daniel Devers officer: EVP & Chief Legal Officer 2800 ROCKCREEK PARKWAY NORTH KANSAS CITY MO 64117
Mark J Erceg officer: Exec. VP & CFO 248 E. SKYLINE DRIVE, WASHINGTON UT 84780
William D Zollars director 10777 BARKLEY, PO BOX 7563, OVERLAND PARK KS 66207-0563
Travis Dalton officer: EVP & Chief Client & Serv. Off 2800 ROCKCREEK PARKWAY NORTH KANSAS CITY MO 64117
John Peterzalek other: President, Cerner South East
Elder Granger director 5176 S. LEWISTON WAY, CENTENNIAL CO 80015
George Andrew Riedel director C/O NORTEL NETWORKS CORPORATION, 8200 DIXIE ROAD, SUITE 100, BRAMPTON A6 L6T 5P6
Bisbee Gerald E Jr director C/O CERNER CORP 2800 ROCKCREEK PARKWAY KANSAS CITY MO 64117-2551
Linda M Dillman director 5221 PRESTWICK NORTH CIRCLE FAYETTEVILLE AR 72704
David Brent Shafer director 2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Donald Trigg officer: SVP 2800 ROCKCREEK PARKWAY NORTH KANSAS CITY MO 64117

Cerner (Cerner) Headlines

From GuruFocus

Agate Pass Investment Management, LLC Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-09-2022

Top 5 2nd Quarter Trades of Capital Investment Services of America, Inc.

By GuruFocus Research GuruFocus Editor 07-06-2022

First Personal Financial Services Cuts Portfolio Down to Size in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-25-2022

SYQUANT CAPITAL SAS Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-08-2022

Top 5 1st Quarter Trades of Jeff Auxier

By GuruFocus Research GuruFocus Editor 05-17-2022

George Soros Games With Zynga in 1st Quarter

By Margaret Moran 05-17-2022

Top 5 2nd Quarter Trades of PICTON MAHONEY ASSET MANAGEMENT

By GuruFocus Research GuruFocus Editor 08-08-2022

Arizona State Retirement System Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-28-2022

Top 5 2nd Quarter Trades of EADS & HEALD WEALTH MANAGEMENT

By GuruFocus Research GuruFocus Editor 07-26-2022